S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
IMAX · Imax Corp
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
$53.11
+0.63
(+1.20%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$53.11
$52.15
$53.46
52-WEEK RANGE
$53.11
$31.27
$57.73
What's happening
- IMAX is up 1.20% today, trading at $53.11. — Live quote
- Volume today (32,938) is well below its 3-month average of 1,188,820. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.43 actual vs. $0.29 estimated (+50.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 13
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (20 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IMAX
+41.88%
vs S&P 500
+29.11%
1-YEAR RETURN
IMAX
+61.65%
vs S&P 500
+47.09%
6-MONTH RETURN
IMAX
+41.35%
3-MONTH RETURN
IMAX
+38.55%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.43
Est. $0.29
BEAT +50.8%
2026-04-26 (Q1 2026)
$0.17
Est. $0.15
BEAT +9.8%
2026-01-26 (Q4 2025)
$0.58
Est. $0.46
BEAT +25.1%
2025-10-26 (Q3 2025)
$0.47
Est. $0.39
BEAT +20.7%
Valuation Measures & Ratios
Enterprise Value4$2.99B
Forward P/E525.17
PEG Ratio63.32
Price / Sales (TTM1)6.90
Price / Book76.16
EV4 / Revenue7.20
EV4 / EBITDA32.53
Profit Margin9.84%
Operating Margin20.16%
Return on Equity (ROE8)11.87%
Return on Assets (ROA9)4.55%
Avg Volume (3M)1,188,820
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $2.27B | $2.30B | $1.83B | $1.57B | $1.53B |
| P/E | 44.12 | 59.70 | 37.99 | 50.62 | 66.35 |
| Price/Sales | 5.94 | 6.27 | 4.86 | 4.38 | 4.42 |
| Price/Book | 6.39 | 6.85 | 5.23 | 4.91 | 5.11 |
| EV/Revenue | 5.53 | 5.87 | 4.48 | 4.08 | 4.14 |
| EV/EBITDA | 15.48 | 16.33 | 11.97 | — | — |
| ROE | 14.48% | 11.47% | 13.77% | 9.69% | 7.71% |
| ROA | 5.62% | 4.31% | 5.41% | 3.58% | 2.72% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short6,673,373
Change from Prior Settlement+0.83%
% of Float—
Days to Cover (Short Ratio)6.34
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 12.2% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +61.7%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 9.8%. Finnhub fundamentals ↗
- Trailing P/E is 70.2, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-02; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IMAX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $102.8M | $81.4M | $106.7M | $91.7M | $86.7M | $91.5M | $89.0M | $79.1M |
| Gross profit | $62.9M | $45.8M | $67.3M | $53.6M | $53.2M | $51.0M | $43.9M | $46.9M |
| Operating income | $20.8M | $10.0M | $29.0M | $14.3M | $16.7M | $19.4M | $2.9M | $12.1M |
| Net income | $15.4M | $4.2M | $20.7M | $11.3M | $2.3M | $13.9M | $3.6M | $3.3M |
| EPS (diluted) | $0.27 | $0.07 | $0.37 | $0.20 | $0.04 | $0.26 | $0.07 | $0.06 |
| EPS (basic) | $0.28 | $0.08 | $0.38 | $0.21 | $0.04 | $0.26 | $0.07 | $0.06 |
| Operating margin | $20 | $12 | $27 | $16 | $19 | $21 | $3 | $15 |
| Net margin | $15 | $5 | $19 | $12 | $3 | $15 | $4 | $4 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $917.9M | $893.2M | $894.0M | $889.6M | $868.6M | $848.3M | $830.4M | $847.6M |
| Total liabilities | $467.5M | $464.8M | $466.3M | $452.9M | $463.5M | $464.0M | $452.2M | $479.8M |
| Stockholders' equity | $355.9M | $335.5M | $337.9M | $349.5M | $320.4M | $299.5M | $299.5M | $289.4M |
| Cash & equivalents | $159.9M | $146.0M | $151.2M | $143.1M | $109.3M | $97.1M | $100.6M | $104.5M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $114.6M | $108.5M | $108.1M | $108.4M | $126.9M | $122.3M | $107.7M | $114.2M |
| Inventory | $39.2M | $35.8M | $32.5M | $41.4M | $36.7M | $31.7M | $32.8M | $37.6M |
| Property, plant & equipment | $238.9M | $240.9M | $242.9M | $243.8M | $243.7M | $245.1M | $240.1M | $245.1M |
| Goodwill | $45.8M | $45.8M | $45.8M | $52.8M | $52.8M | $52.8M | $52.8M | $52.8M |
| Intangible assets | $29.7M | $30.9M | $32.4M | $33.5M | $34.3M | $35.0M | $35.1M | $34.3M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $441.3M | $429.6M | $419.2M | $415.6M | $415.1M | $414.0M | $401.4M | $394.6M |
| Retained earnings | -$230.8M | -$235.7M | -$240.0M | -$240.6M | -$261.3M | -$272.4M | -$274.7M | -$280.0M |
| Accumulated other comprehensive income (loss) | -$7.1M | -$8.7M | -$10.3M | -$11.7M | -$13.6M | -$16.0M | -$16.6M | -$11.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $32.0M | $4.0M | $29.4M | $67.5M | $23.2M | $7.0M | $11.5M | $35.3M |
| Investing cash flow | -$6.1M | -$6.9M | -$7.1M | -$12.7M | -$7.4M | -$14.6M | -$10.9M | -$14.7M |
| Financing cash flow | -$11.5M | -$2.8M | -$13.7M | -$20.9M | -$3.8M | $4.2M | -$5.1M | -$7.6M |
| Free cash flow | $32.0M | $1.9M | $28.0M | $64.8M | $20.9M | $5.3M | $6.9M | $34.2M |
| Capital expenditures | $21.0K | $2.1M | $1.4M | $2.7M | $2.4M | $1.6M | $4.6M | $1.1M |
| Depreciation & amortization | $15.7M | $15.2M | $16.0M | $15.6M | $15.9M | $14.9M | $16.6M | $14.9M |
| Share-based compensation | $7.3M | $5.7M | $21.4M | $6.3M | $7.4M | $5.2M | $18.1M | $5.4M |
| Deferred income taxes | $273.0K | -$35.0K | $38.0K | $662.0K | $72.0K | $0 | $1.7M | $383.0K |
| Change in accounts receivable | $7.8M | $751.0K | $188.0K | -$17.6M | $3.7M | $15.0M | -$6.1M | -$8.5M |
| Change in inventory | — | — | — | — | — | — | — | — |
| Change in accounts payable | $5.3M | -$2.2M | -$3.1M | -$9.1M | $6.5M | $5.1M | -$6.1M | $5.9M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Other investing activities | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | $0 | — | $0 |
| Tax withholding on stock comp | $428.0K | $17.5M | $0 | $0 | $237.0K | $9.5M | $0 | $0 |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $410.2M | $352.2M | $374.8M | $300.8M | $254.9M |
| Gross profit | $246.2M | $190.2M | $214.3M | $156.4M | $134.4M |
| Operating income | $84.2M | $43.9M | $50.4M | -$4.8M | $11.0M |
| Net income | $34.9M | $26.1M | $25.3M | -$22.8M | -$22.3M |
| EPS (diluted) | $0.63 | $0.48 | $0.46 | $-0.40 | $-0.38 |
| EPS (basic) | $0.65 | $0.49 | $0.47 | $-0.40 | $-0.38 |
| Operating margin | $21 | $12 | $13 | -$2 | $4 |
| Net margin | $9 | $7 | $7 | -$8 | -$9 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $894.0M | $830.4M | $814.7M | $821.2M | $883.2M |
| Total liabilities | $466.3M | $452.2M | $469.1M | $491.4M | $452.9M |
| Stockholders' equity | $337.9M | $299.5M | $273.1M | $263.4M | $356.1M |
| Cash & equivalents | $151.2M | $100.6M | $76.2M | $97.4M | $189.7M |
| Marketable securities (current) | — | — | — | — | — |
| Accounts receivable | $108.1M | $107.7M | $136.3M | $136.1M | $110.0M |
| Inventory | $32.5M | $32.8M | $31.6M | $31.5M | $26.9M |
| Property, plant & equipment | $242.9M | $240.1M | $243.3M | $252.9M | $260.4M |
| Goodwill | $45.8M | $52.8M | $52.8M | $52.8M | $39.0M |
| Intangible assets | $32.4M | $35.1M | $35.0M | $32.7M | $23.1M |
| Accrued liabilities | — | — | — | — | — |
| Long-term debt | — | — | — | — | $2.5M |
| Common stock & paid-in capital | $419.2M | $401.4M | $389.0M | $376.7M | $410.0M |
| Retained earnings | -$240.0M | -$274.7M | -$292.8M | -$293.1M | -$235.0M |
| Accumulated other comprehensive income (loss) | -$10.3M | -$16.6M | -$12.1M | -$9.8M | $2.5M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $127.1M | $70.8M | $58.6M | $17.3M | $6.1M |
| Investing cash flow | -$41.9M | -$41.2M | -$31.8M | -$53.3M | -$7.0K |
| Financing cash flow | -$34.1M | -$6.0M | -$48.5M | -$58.5M | -$132.7M |
| Free cash flow | $118.9M | $62.4M | $52.1M | $8.9M | $2.5M |
| Capital expenditures | $8.2M | $8.4M | $6.5M | $8.4M | $3.6M |
| Depreciation & amortization | $62.4M | $65.5M | $60.0M | $56.7M | $56.1M |
| Share-based compensation | $26.6M | $22.8M | $23.6M | $27.0M | $25.6M |
| Deferred income taxes | $772.0K | -$5.6M | -$1.4M | -$2.1M | $3.0M |
| Change in accounts receivable | $1.3M | -$29.1M | $1.9M | $29.0M | $52.5M |
| Change in inventory | — | — | — | — | — |
| Change in accounts payable | -$481.0K | -$6.4M | -$535.0K | $8.5M | -$4.8M |
| Purchases of investments | — | — | — | — | — |
| Other investing activities | — | — | — | — | — |
| Share repurchases | — | — | — | — | $13.9M |
| Tax withholding on stock comp | $9.7M | $5.0M | $6.5M | $3.7M | $3.7M |
| Other financing activities | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IMAX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-07 to 2026-09-10
Recent transactions
- Insiders have net sold 561,700 shares over the last 182 days, across 0 purchases and 10 sales.
- Most recent: LISTER ROBERT D (Chief Legal Officer Sr Exec VP) — Open market sale of 22,500 shares on 2026-09-10.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)561,700 sh(10 txns)
Net Shares-561,700
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| LISTER ROBERT D | Chief Legal Officer Sr Exec VP | Open market sale | 2026-09-10 | 22,500 |
| WELTON MARK | President IMAX Global Theatres | Open market sale | 2026-08-25 | 30,000 |
| Weissman Kenneth Ian | Deputy GC, Corp. Sec. & CCO | Open market sale | 2026-08-25 | 8,000 |
| Fernandes Natasha | Chief Financial Officer & EVP | Open market sale | 2026-08-24 | 20,000 |
| PABLO CALAMERA | CTO & EVP | Open market sale | 2026-08-20 | 15,000 |
| GELFOND RICHARD L | Chief Executive Officer | Open market sale | 2026-08-20 | 100,000 |
| Zlatar Jose Aleksandr | SVP, Controller & PAO | Open market sale | 2026-08-06 | 500 |
| Throop Darren D | Reporting person | Option exercise | 2026-06-11 | 4,611 |
| MacMillan Michael | Reporting person | Option exercise | 2026-06-11 | 3,390 |
| Demirian Eric A | Reporting person | Option exercise | 2026-06-11 | 3,390 |
| SETTLE DANA R | Reporting person | Option exercise | 2026-06-11 | 3,390 |
| Wong Jennifer L. | Reporting person | Option exercise | 2026-06-11 | 3,390 |
| Pamon Steve | Reporting person | Option exercise | 2026-06-11 | 3,390 |
| Berman Gail | Reporting person | Option exercise | 2026-06-11 | 3,390 |
| LEEBRON DAVID W | Reporting person | Option exercise | 2026-06-11 | 3,390 |
| DOUGLAS KEVIN | Reporting person | Grant / award | 2026-06-11 | 3,390 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-10 | LISTER ROBERT D | Chief Legal Officer Sr Exec VP | Open market sale | 22,500 | $51.58 |
| 2026-08-25 | WELTON MARK | President IMAX Global Theatres | Open market sale | 30,000 | $54.47 |
| 2026-08-25 | Weissman Kenneth Ian | Deputy GC, Corp. Sec. & CCO | Open market sale | 8,000 | $54.54 |
| 2026-08-24 | Fernandes Natasha | Chief Financial Officer & EVP | Open market sale | 20,000 | $54.63 |
| 2026-08-20 | PABLO CALAMERA | CTO & EVP | Open market sale | 15,000 | $52.41 |
| 2026-08-20 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 100,000 | $53.23 |
| 2026-08-19 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 205,504 | $31.90 |
| 2026-08-19 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 205,504 | $53.27 |
| 2026-08-18 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 151,253 | $31.90 |
| 2026-08-18 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 151,253 | $51.00 |
| 2026-08-06 | Zlatar Jose Aleksandr | SVP, Controller & PAO | Open market sale | 500 | $49.90 |
| 2026-06-11 | Throop Darren D | Reporting person | Option exercise | 4,611 | $0.00 |
| 2026-06-11 | Throop Darren D | Reporting person | Tax withholding | 2,474 | $42.12 |
| 2026-06-11 | MacMillan Michael | Reporting person | Option exercise | 3,390 | $0.00 |
| 2026-06-11 | MacMillan Michael | Reporting person | Tax withholding | 1,849 | $42.12 |
| 2026-06-11 | Demirian Eric A | Reporting person | Option exercise | 3,390 | $0.00 |
| 2026-06-11 | Demirian Eric A | Reporting person | Tax withholding | 1,842 | $42.12 |
| 2026-06-11 | SETTLE DANA R | Reporting person | Option exercise | 3,390 | $0.00 |
| 2026-06-11 | Wong Jennifer L. | Reporting person | Option exercise | 3,390 | — |
| 2026-06-11 | Pamon Steve | Reporting person | Option exercise | 3,390 | $0.00 |
| 2026-06-11 | Berman Gail | Reporting person | Option exercise | 3,390 | $0.00 |
| 2026-06-11 | LEEBRON DAVID W | Reporting person | Option exercise | 3,390 | $0.00 |
| 2026-06-11 | DOUGLAS KEVIN | Reporting person | Grant / award | 3,390 | $0.00 |
| 2026-04-27 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 8,943 | $31.40 |
| 2026-04-27 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 8,943 | $37.33 |
| 2026-04-17 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 34,182 | $31.40 |
| 2026-04-17 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 34,182 | $37.06 |
| 2026-04-16 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 41,737 | $31.40 |
| 2026-04-16 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 41,737 | $37.05 |
| 2026-04-15 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 15,746 | $31.40 |
| 2026-04-15 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 15,746 | $37.07 |
| 2026-04-14 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 6,924 | $31.40 |
| 2026-04-14 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 6,924 | $37.07 |
| 2026-04-13 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 97,462 | $31.40 |
| 2026-04-13 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 97,462 | $37.15 |
| 2026-04-10 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 135,046 | $31.40 |
| 2026-04-10 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 135,046 | $37.82 |
| 2026-04-06 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 12,987 | $31.40 |
| 2026-04-06 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 12,987 | $40.26 |
| 2026-04-02 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 12,037 | $31.40 |
| 2026-04-02 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 12,037 | $40.00 |
| 2026-03-16 | DOUGLAS KEVIN | Reporting person | Open market sale | 330,200 | $37.82 |
| 2026-03-16 | DOUGLAS KEVIN | Reporting person | Open market sale | 62,600 | $37.82 |
| 2026-03-16 | DOUGLAS KEVIN | Reporting person | Open market sale | 43,800 | $37.82 |
| 2026-03-16 | DOUGLAS KEVIN | Reporting person | Open market sale | 43,800 | $37.82 |
| 2026-03-16 | DOUGLAS KEVIN | Reporting person | Open market sale | 43,800 | $37.82 |
| 2026-03-16 | DOUGLAS KEVIN | Reporting person | Open market sale | 43,800 | $37.82 |
| 2026-03-10 | GELFOND RICHARD L | Chief Executive Officer | Derivative conversion | 121,220 | $31.40 |
| 2026-03-10 | GELFOND RICHARD L | Chief Executive Officer | Open market sale | 121,220 | $40.10 |
| 2026-03-07 | GELFOND RICHARD L | Chief Executive Officer | Grant / award | 196,964 | $0.00 |
| 2026-03-07 | GELFOND RICHARD L | Chief Executive Officer | Grant / award | 91,768 | $0.00 |
| 2026-03-07 | GELFOND RICHARD L | Chief Executive Officer | Tax withholding | 159,670 | $40.80 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 00:36 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-02 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-10 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-25 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-25 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-21 | 8-K | 2026-08-19 | View on SEC.gov → |
| 2026-08-21 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-07-23 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-23 | 8-K | 2026-07-23 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-11 | View on SEC.gov → |
Recent news
Headlines about IMAX (Imax Corp). Links open the publisher — we don’t host full articles.
-
Blade Runner 2049, Apocalypse Now & La La Land | IMAX Theater at Indiana State Museum hosting 'Revivals Festival' after new upgrades
Yahoo · 2026-10-21 -
Will Imax (IMAX) Beat Estimates Again in Its Next Earnings Report?
Yahoo · 2026-10-21 -
IMAX Corporation (NYSE:IMAX) Stock Rated "Moderate Buy" by Sell-Side Analysts
MarketBeat · 2026-10-21 -
Wedbush raises target to USD 60 for IMAX stock
AD HOC NEWS · 2026-10-20 -
IMAX (IMAX) Stock May Be 22% Undervalued As Record Box Office Surges
Simply Wall Street · 2026-10-20 -
IMAX Nov 2026 40.000 put (IMAX261120P00040000) interactive stock chart
Yahoo Finance Australia · 2026-10-20 -
IMAX261120P00040000 interactive stock chart | IMAX Nov 2026 40.000 put stock
Yahoo Finance Australia · 2026-10-20 -
IMAX Nov 2026 40.000 put (IMAX261120P00040000) stock price, news, quote and history
Yahoo Finance Australia · 2026-10-20
No headlines in this category right now — try “All”.